Cardiac Clearance vs G60 Hip Frailty Index

March 18, 2026 updated by: Methodist Health System

Cardiac Clearance vs G60 Hip Frailty Index in Trauma

The primary objective of this study is to establish a data repository that will be permissive of quality improvement studies/observations specific to postoperative mortality outcomes for geriatric patients with orthopedic injuries based on Orthopedic Hip Frailty Score and preoperative cardiac clearance predictors.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

It is typically a result of advanced aging. Among geriatric patients suffering from hip fractures, frailty is common and is associated with an increased risk of postoperative complications and morbidity with hip fracture surgery. Developed by the Swedish National Quality Registry, the Orthopedic Hip Frailty Score aims to predict short-term postoperative mortality in geriatric patients with hip fractures in order to improve patient outcomes and better allocate resources.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Among geriatric patients suffering from hip fractures, frailty is common and is associated with an increased risk of postoperative complications and morbidity with hip fracture surgery.

Description

Inclusion Criteria:

≥60 years old Included in the Methodist Dallas Medical Center Trauma Registry Documented orthopedic injury with surgical management

Exclusion Criteria:

<60 years old Prisoners, pregnant persons, or other protected populations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Total Number and Description of Study Sites/Total Number of Subjects Projected
This study will include all geriatric trauma patients at Methodist Dallas Medical Center who meet registry inclusion and have an operative orthopedic injury. Enrollment will terminate once five years of data are captured: January 2018 through December 2023.
Other: Medical/Phenotype Data Collection Procedures & Data to be Collected
The Methodist Dallas Medical Center Trauma Registry will be queried for demographic information, diagnosis codes, admission dates, traumatic injury characteristics, surgical procedures, comorbidities, inpatient outcomes, complications, consultations, discharge location, and mortality.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Number and Description of Study Sites/Total Number of Subjects Projected
Time Frame: 5 years
This study will include all geriatric trauma patients at Methodist Dallas Medical Center who meet registry inclusion and have an operative orthopedic injury. Enrollment will terminate once five years of data are captured: January 2018 through December 2023.
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Methodist Health System

Investigators

  • Principal Investigator: Jennifer Burris, MD, Methodist Health System

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2028

Study Registration Dates

First Submitted

March 18, 2026

First Submitted That Met QC Criteria

March 18, 2026

First Posted (Actual)

March 24, 2026

Study Record Updates

Last Update Posted (Actual)

March 24, 2026

Last Update Submitted That Met QC Criteria

March 18, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 058.TRA.2023.D

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All information will be blinded in compliance with Good Clinical Practice. The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of protected health information or research information. Only de-identified protected health information will be shared in relevant research mediums.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Disease

Clinical Trials on Medical/Phenotype Data Collection Procedures & Data to be Collected

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe